2023-2029 Global PD-1/PD-L1 Inhibitors for Weight Loss Industry Research & Trends Analysis Report
This report aims to provide a comprehensive study of the global market for PD-1/PD-L1 Inhibitors for Weight Loss.
Report Highlights:
(1) Global PD-1/PD-L1 Inhibitors for Weight Loss market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global PD-1/PD-L1 Inhibitors for Weight Loss market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China PD-1/PD-L1 Inhibitors for Weight Loss market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global PD-1/PD-L1 Inhibitors for Weight Loss segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global PD-1/PD-L1 Inhibitors for Weight Loss segment by type and by application and regional segment by type and by application.
(6) Global major production regions of PD-1/PD-L1 Inhibitors for Weight Loss, capacity, production and trends.
(7) PD-1/PD-L1 Inhibitors for Weight Loss industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for PD-1/PD-L1 Inhibitors for Weight Loss should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China PD-1/PD-L1 Inhibitors for Weight Loss market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States PD-1/PD-L1 Inhibitors for Weight Loss market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, PD-1 Inhibitors segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Woman has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss include Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine and Junshi Biosciences, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
PD-1 Inhibitors
PD-L1 Inhibitors
By Applications, the market is segmented into:
Woman
Man
Key Players Driving the Market:
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
1 Market Overview
1.1 PD-1/PD-L1 Inhibitors for Weight Loss Definition
1.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast
1.2.1 By Revenue, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
1.2.2 By Sales Volume, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
1.2.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Price Trend, 2018-2029
1.3 China PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast
1.3.1 By Revenue, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
1.3.2 By Sales Volume, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
1.3.3 China PD-1/PD-L1 Inhibitors for Weight Loss Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China PD-1/PD-L1 Inhibitors for Weight Loss Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China PD-1/PD-L1 Inhibitors for Weight Loss Share in Global Market, 2018-2029
1.4.3 PD-1/PD-L1 Inhibitors for Weight Loss Market Size: China VS Global, 2018-2029
1.5 PD-1/PD-L1 Inhibitors for Weight Loss Market Dynamics
1.5.1 PD-1/PD-L1 Inhibitors for Weight Loss Market Drivers
1.5.2 PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
1.5.3 PD-1/PD-L1 Inhibitors for Weight Loss Industry Trends
1.5.4 PD-1/PD-L1 Inhibitors for Weight Loss Industry Policy
2 Global Competitive Landscape by Company
2.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Company, 2018-2023
2.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume by Company, 2018-2023
2.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Price by Company, 2018-2023
2.4 Global PD-1/PD-L1 Inhibitors for Weight Loss Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global PD-1/PD-L1 Inhibitors for Weight Loss Concentration Ratio
2.6 Global PD-1/PD-L1 Inhibitors for Weight Loss Mergers & Acquisitions, Expansion Plans
2.7 Global PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Company, 2018-2023
3.2 China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume by Company, 2018-2023
3.3 China PD-1/PD-L1 Inhibitors for Weight Loss PD-1/PD-L1 Inhibitors for Weight Loss Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China PD-1/PD-L1 Inhibitors for Weight Loss Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, PD-1/PD-L1 Inhibitors for Weight Loss Domestic VS Export
3.6 China Market, PD-1/PD-L1 Inhibitors for Weight Loss Import & Export
3.6.1 China Market, PD-1/PD-L1 Inhibitors for Weight Loss Import & Export, 2018-2029
3.6.2 China PD-1/PD-L1 Inhibitors for Weight Loss Import & Export Trends
3.6.3 Main Sources of China PD-1/PD-L1 Inhibitors for Weight Loss Import
3.6.4 Export Destination of China PD-1/PD-L1 Inhibitors for Weight Loss
4 PD-1/PD-L1 Inhibitors for Weight Loss Production by Region
4.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers
4.3 Global Major Manufacturers, PD-1/PD-L1 Inhibitors for Weight Loss Capacity Expansion and Future Plans
4.4 Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity by Region
4.5 Global PD-1/PD-L1 Inhibitors for Weight Loss Production by Region
4.5.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Production by Region, 2018-2023
4.5.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 PD-1/PD-L1 Inhibitors for Weight Loss Industry Chain
5.2 PD-1/PD-L1 Inhibitors for Weight Loss Upstream Analysis
5.2.1 PD-1/PD-L1 Inhibitors for Weight Loss Core Raw Materials
5.2.2 Main Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 PD-1/PD-L1 Inhibitors for Weight Loss Production Mode
5.6 PD-1/PD-L1 Inhibitors for Weight Loss Procurement Model
5.7 PD-1/PD-L1 Inhibitors for Weight Loss Industry Sales Model and Sales Channels
5.7.1 PD-1/PD-L1 Inhibitors for Weight Loss Sales Model
5.7.2 PD-1/PD-L1 Inhibitors for Weight Loss Typical Distributors
6 Sights by Type
6.1 PD-1/PD-L1 Inhibitors for Weight Loss Classification
6.1.1 PD-1 Inhibitors
6.1.2 PD-L1 Inhibitors
6.2 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029
6.4 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029
6.5 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Price, 2018-2029
7 Sights by Application
7.1 PD-1/PD-L1 Inhibitors for Weight Loss Segment by Application
7.1.1 Woman
7.1.2 Man
7.2 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029
7.4 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029
7.5 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029
8.3 By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029
8.4 North America
8.4.1 North America PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.5 Europe
8.5.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.7 South America
8.7.1 South America PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029
9.3 By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.4.2 By Company, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.4.3 By Type, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.5.2 By Company, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.5.3 By Type, Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.6.2 By Company, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.6.3 By Type, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.6.4 By Application, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.7.2 By Company, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.7.3 By Type, Japan PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.8.2 By Company, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.8.3 By Type, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.9.2 By Company, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.10.2 By Company, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.10.3 By Type, India PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.10.4 By Application, India PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.1.3 Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information, Head Office, Market Area and Industry Position
10.2.2 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.2.3 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Bristol-Myers Squibb Company Profile and Main Business
10.2.5 Bristol-Myers Squibb Recent Developments
10.3 Roche
10.3.1 Roche Company Information, Head Office, Market Area and Industry Position
10.3.2 Roche PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.3.3 Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Roche Company Profile and Main Business
10.3.5 Roche Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.4.2 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.4.3 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Ono Pharmaceutical
10.5.1 Ono Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.5.2 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.5.3 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Ono Pharmaceutical Company Profile and Main Business
10.5.5 Ono Pharmaceutical Recent Developments
10.6 Regeneron
10.6.1 Regeneron Company Information, Head Office, Market Area and Industry Position
10.6.2 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.6.3 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Regeneron Company Profile and Main Business
10.6.5 Regeneron Recent Developments
10.7 Innovent
10.7.1 Innovent Company Information, Head Office, Market Area and Industry Position
10.7.2 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.7.3 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Innovent Company Profile and Main Business
10.7.5 Innovent Recent Developments
10.8 Hengrui Medicine
10.8.1 Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
10.8.2 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.8.3 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Hengrui Medicine Company Profile and Main Business
10.8.5 Hengrui Medicine Recent Developments
10.9 Junshi Biosciences
10.9.1 Junshi Biosciences Company Information, Head Office, Market Area and Industry Position
10.9.2 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.9.3 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Junshi Biosciences Company Profile and Main Business
10.9.5 Junshi Biosciences Recent Developments
10.10 Merck KGaA
10.10.1 Merck KGaA Company Information, Head Office, Market Area and Industry Position
10.10.2 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
10.10.3 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merck KGaA Company Profile and Main Business
10.10.5 Merck KGaA Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. PD-1/PD-L1 Inhibitors for Weight Loss Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
Table 3. PD-1/PD-L1 Inhibitors for Weight Loss Market Trends
Table 4. PD-1/PD-L1 Inhibitors for Weight Loss Industry Policy
Table 5. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Company, 2018-2023, US$ million
Table 6. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Company, 2018-2023
Table 7. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share by Company, 2018-2023
Table 9. Global PD-1/PD-L1 Inhibitors for Weight Loss Price by Company, 2018-2023, (US$/Unit)
Table 10. Global PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global PD-1/PD-L1 Inhibitors for Weight Loss Mergers & Acquisitions, Expansion Plans
Table 12. Global PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers Product Type
Table 13. China PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Company, 2018-2023, US$ million
Table 14. China PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Company, 2018-2023
Table 15. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume by Company, 2018-2023, (K Units)
Table 16. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, PD-1/PD-L1 Inhibitors for Weight Loss Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China PD-1/PD-L1 Inhibitors for Weight Loss Import & Export Trends
Table 19. Main Sources of China PD-1/PD-L1 Inhibitors for Weight Loss Import
Table 20. Export Destination of China PD-1/PD-L1 Inhibitors for Weight Loss
Table 21. Global Headquarters and Manufacturing Base of PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers
Table 22. Global Major Manufacturers, PD-1/PD-L1 Inhibitors for Weight Loss Capacity Expansion and Future Plans
Table 23. Global PD-1/PD-L1 Inhibitors for Weight Loss Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global PD-1/PD-L1 Inhibitors for Weight Loss Production by Region, 2018-2023, (K Units)
Table 25. Global PD-1/PD-L1 Inhibitors for Weight Loss Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of PD-1/PD-L1 Inhibitors for Weight Loss Upstream (Raw Materials)
Table 27. Global PD-1/PD-L1 Inhibitors for Weight Loss Typical Customers
Table 28. PD-1/PD-L1 Inhibitors for Weight Loss Typical Distributors
Table 29. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029, US$ Million
Table 33. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029, US$ Million
Table 36. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2018-2029
Table 37. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2018-2029
Table 39. Merck Company Information, Head Office, Market Area and Industry Position
Table 40. Merck PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 41. Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. Bristol-Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 45. Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 46. Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Bristol-Myers Squibb Company Profile and Main Business
Table 48. Bristol-Myers Squibb Recent Developments
Table 49. Roche Company Information, Head Office, Market Area and Industry Position
Table 50. Roche PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 51. Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Roche Company Profile and Main Business
Table 53. Roche Recent Developments
Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 55. AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 56. AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AstraZeneca Company Profile and Main Business
Table 58. AstraZeneca Recent Developments
Table 59. Ono Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 60. Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 61. Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Ono Pharmaceutical Company Profile and Main Business
Table 63. Ono Pharmaceutical Recent Developments
Table 64. Regeneron Company Information, Head Office, Market Area and Industry Position
Table 65. Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 66. Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Regeneron Company Profile and Main Business
Table 68. Regeneron Recent Developments
Table 69. Innovent Company Information, Head Office, Market Area and Industry Position
Table 70. Innovent PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 71. Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Innovent Company Profile and Main Business
Table 73. Innovent Recent Developments
Table 74. Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
Table 75. Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 76. Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Hengrui Medicine Company Profile and Main Business
Table 78. Hengrui Medicine Recent Developments
Table 79. Junshi Biosciences Company Information, Head Office, Market Area and Industry Position
Table 80. Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 81. Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Junshi Biosciences Company Profile and Main Business
Table 83. Junshi Biosciences Recent Developments
Table 84. Merck KGaA Company Information, Head Office, Market Area and Industry Position
Table 85. Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications and Application
Table 86. Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Merck KGaA Company Profile and Main Business
Table 88. Merck KGaA Recent Developments
List of Figure
Figure 1. PD-1/PD-L1 Inhibitors for Weight Loss Picture
Figure 2. By Revenue, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global PD-1/PD-L1 Inhibitors for Weight Loss Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China PD-1/PD-L1 Inhibitors for Weight Loss Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China PD-1/PD-L1 Inhibitors for Weight Loss Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China PD-1/PD-L1 Inhibitors for Weight Loss Share of Global Market, 2018-2029
Figure 10. Global PD-1/PD-L1 Inhibitors for Weight Loss Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China PD-1/PD-L1 Inhibitors for Weight Loss Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China PD-1/PD-L1 Inhibitors for Weight Loss Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China PD-1/PD-L1 Inhibitors for Weight Loss Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of PD-1/PD-L1 Inhibitors for Weight Loss Domestic VS Export, 2022
Figure 16. Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global PD-1/PD-L1 Inhibitors for Weight Loss Production Market Share & Forecast by Region, 2018-2029
Figure 19. PD-1/PD-L1 Inhibitors for Weight Loss Industry Chain
Figure 20. PD-1/PD-L1 Inhibitors for Weight Loss Procurement Model
Figure 21. PD-1/PD-L1 Inhibitors for Weight Loss Sales Model
Figure 22. PD-1/PD-L1 Inhibitors for Weight Loss Sales Channels, Direct Sales and Distribution
Figure 23. PD-1 Inhibitors
Figure 24. PD-L1 Inhibitors
Figure 25. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2018-2029
Figure 27. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Price, 2018-2029, (US$/Unit)
Figure 30. Woman
Figure 31. Man
Figure 32. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2018-2029
Figure 34. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 35. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Price, 2018-2029, (US$/Unit)
Figure 37. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2018-2029
Figure 38. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2018-2029
Figure 39. North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2022
Figure 41. Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2022
Figure 43. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2022
Figure 45. South America PD-1/PD-L1 Inhibitors for Weight Loss Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share, 2022
Figure 47. Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 49. By Company, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 50. By Type, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 54. By Type, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 56. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, China PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 58. By Type, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Japan PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 62. By Type, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 66. By Type, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 68. Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 70. By Type, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 72. India PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, India PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 74. By Type, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 76. Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Share, 2022
Figure 78. By Type, Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Middle East & Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Volume Market Share, 2022 VS 2029
Figure 80. Research Methodology
Figure 81. Breakdown of Primary Interviews
Figure 82. Bottom-up Approaches
Figure 83. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|